What insurance policy changes affect code J12.89?

There are 1 tracked policy change affecting code J12.89, including updates from Aetna. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for code J12.89?

Payers that have issued tracked updates for code J12.89 include: Aetna.

How do I get notified when code J12.89 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to code J12.89. You will get an email when new policy changes reference this code: daily or weekly, your choice, on every plan.

Why do payers change policies for code J12.89?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

PAYER POLICY CHANGES

J12.89 Insurance Policy Changes

ICD-10 J12.89 is officially defined as "Other viral pneumonia." code J12.89 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for code J12.89 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Only a small number of policies match this filter. Check back as coverage expands.

Aetna · Identified Oct 2, 2026Medium impact
Extracorporeal Membrane Oxygenation (ECMO) (CPB 0546, reviewed 2026-08-27)
Aetna considers ECMO medically necessary for neonates who meet all of these criteria: a listed diagnosis (congenital diaphragmatic hernia, hyaline membrane disease, meconium aspiration, persistent fetal circulation, possible cardiac anomaly, refractory neonatal septic shock, respiratory distress syndrome, or uncontrollable air leak), gestational age of at least 34 weeks, birth weight of 2,000 grams or greater, and age less than 10 days (preferably less than 7 days). For children and adults, ECMO and extracorporeal life support are considered medically necessary for listed diagnoses when the risk of death is very high despite optimal conventional therapy, including ARDS, a short-term bridge to heart, liver, lung or heart-lung transplantation or to durable mechanical circulatory support, support following heart surgery to ease the transition from cardiopulmonary bypass to ventilation, non-necrotizing pneumonias, primary graft failure after transplant, pulmonary contusion, refractory pediatric septic shock, smoke inhalation injury, and other reversible causes of respiratory or cardiac failure unresponsive to all other measures. Aetna considers ECMO experimental, investigational, or unproven for all other indications, including acute coronary syndromes, acute massive pulmonary embolism, burns not accompanied by ARDS, cardiogenic shock or smoke inhalation injury, sepsis other than refractory pediatric septic shock, refractory status asthmaticus, tuberculosis, and drug overdose.

Watch J12.89

Get one email when a payer policy names J12.89, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.

Create a free alert How Policy Monitoring works

Extracorporeal Membrane Oxygenation (ECMO) (CPB 0546, reviewed 2026-08-27)

What insurance policy changes affect code J12.89?

Which payers have updated policy for code J12.89?

How do I get notified when code J12.89 policy changes?

Why do payers change policies for code J12.89?